Labeling and Packaging. Seller shall label and package Products in accordance with applicable Legal Requirements and Specifications and shall include a unique identifying lot number.
Labeling and Packaging. BTG shall label and package the Bulk Product in accordance with Legal Requirements applicable to pharmaceutical products shipped in bulk for further processing, labeling, or repackaging.
Labeling and Packaging. Regeneron shall provide the Regeneron Product to Sponsor in the form of unlabeled vials, and Sponsor shall be responsible for labeling, packaging and leafleting such Regeneron Product in accordance with the terms and conditions of the applicable Clinical Supply Quality Agreement and otherwise in accordance with all Applicable Law, including applicable cGMP, GCP, and health, safety and environmental protections. Sponsor shall be responsible for labeling, packaging and leafleting of the Sponsor Product in accordance with all Applicable Law, including applicable cGMP, GCP, and health, safety and environmental protections.
Labeling and Packaging. Rugby shall be responsible for all costs of developing, packaging and labeling for the Product, and shall provide HMRI all art work and pharmacological information, usage instructions and warnings to be applied to each Product, which shall be consistent with the FDA approved labeling for the Products. Rugby shall provide such information pursuant to this Section 2.5 to HMRI a sufficient period of time in advance of delivery requirements for the Products set forth in this Agreement.
Labeling and Packaging. The Supplier shall label and package the Private Label Products pursuant to the Buyer’s Instructions.
Labeling and Packaging. Seller shall not pack Buyer-branded goods until Buyer has approved the applicable package and label design (“Approved Packaging”). In the event that changes to the Approved Packaging are required by Buyer or by applicable law, or in the event that Seller ceases, for any reason, supplying certain Buyer-branded Goods hereunder, Seller shall cease ordering or producing the discontinued Approved Packaging (“Discontinued Packaging”) except as may be reasonably necessary to complete production and packaging of Goods as ordered by Buyer, and shall make good faith efforts to terminate any Orders for Discontinued Packaging previously made but not yet delivered.
Labeling and Packaging. All Product shipped and delivered by Supplier to Purchaser, under this Agreement shall be packaged and labeled in accordance with this Agreement, the then-current packaging and labeling specifications provided by Purchaser, and cGMPs. Prior to the Effective Date, Purchaser supplied Supplier with labeling for the Product {including the NDC number(s) for the Product). Supplier shall print, either directly or through a Third Party, labels and other printed material to be included as part of the Product, From time to time, Purchaser may provide Supplier with modified labeling and upon receipt thereof, Supplier shall use its Commercially Reasonable Efforts to incorporate such new labeling on the Product in accordance with Purchaser’s requested schedule therefore. Purchaser shall provide Supplier with any modifications to the labeling for the Product as promptly as possible in order to ensure compliance with any and all applicable regulations. Purchaser shall reimburse Supplier for all commercially reasonable costs incurred by Supplier in making modifications to labeling, branding, or imprinting packaging and/or manufacturing processes to accommodate Purchaser’s new labeling or to accommodate any other changes requested by Purchaser and agreed to by Supplier. Such reimbursement shall be made pursuant to invoices submitted by Supplier to Purchaser, which invoices shall be payable within [***] days after Purchaser’s receipt thereof. Upon Purchaser’s request, Supplier shall promptly enter into a separate written label agreement with Purchaser, setting forth Supplier’s obligations relating to the labeling of Product hereunder.
Labeling and Packaging. Subject to applicable laws and regulations, the labelling and packaging for the Licensed Products shall bear Metasyn's name, in a form to be mutually agreed upon by the Parties, in addition to MKG's name and trademark.
Labeling and Packaging. (a) Journey shall obtain NDC Numbers for the Journey Product and shall distribute and sell only the Journey Product bearing the applicable NDC Numbers. Blu shall promptly submit to the FDA and DailyMed the Journey Product label under the Blu ANDA . Journey is responsible for other drug listing of their private label Journey Product.
(b) All Journey Products will be private labeled by Blu with the names and trademarks chosen by Journey (the "Journey Product Marks"). As part of the manufacture of Journey Products, Blu shall package and label the Journey Products in accordance with the Specifications. Except as required to fulfill contractual obligations hereunder, Blu shall not apply any trademarks, trade names, logos or other branding items to packaging and labeling for the Products other than (i) Journey Product Marks and (ii) the Blu trademarks set forth in the Specifications. Journey hereby grants Blu a nonexclusive license to use the Journey Product Marks to package and label the Journey Products in accordance with the Specifications. Blu shall not use the Journey Product Marks for any other purpose. Journey shall retain all right, title and interest in and to the Journey Product Marks. All use of the Journey Product Marks shall inure to the benefit of Journey. During the Term and thereafter, Blu shall not in any event (i) register or, any trademark which is confusingly similar to the Journey Product Marks or Journey or (ii) use the Journey Product Marks in any manner whatsoever which may jeopardize the significance, distinctiveness or validity thereof. Blu hereby recognizes the validity of the Journey Product Marks and the registrations thereof, and will not, during the Term or thereafter, contest the validity thereof During the Term and thereafter, Journey shall not in any event (i) register or, any trademark which is confusingly similar to the Blu Product Marks or Blu or (ii) use the Blu Product Marks in any manner whatsoever which may jeopardize the significance, distinctiveness or validity thereof. Journey hereby recognizes the validity of the Blu Product Marks and the registrations thereof, and will not, during the Term or thereafter, contest the validity thereof.
Labeling and Packaging. Arena and Eisai shall discuss and reasonably agree on all technical requirements for packaging configurations, packaging and labeling used with Product in each country in the Territory. Subject to Section 5.3, Arena shall label and package (in appropriate primary, secondary and tertiary packaging), including production of Package Inserts, Product to be supplied in accordance with such agreement of the Parties, the applicable Manufacturing SOPs, and Applicable Laws of each applicable country in the Territory, for delivery to Eisai or the Designated Distributor under this Agreement. Eisai or the Designated Distributor shall be responsible for providing to Arena (or its designees, including printed packaging material vendors utilized by Arena) all artwork for all such labeling, Package Inserts and packaging on a timely basis, for each applicable packaging configuration for each country in the Territory, as necessary for Arena to perform such labeling and packaging, and in formats as reasonably agreed by the Parties and reasonably acceptable to Arena. It is agreed that Arena’s obligations to manufacture and supply Product shall be delayed to the extent Eisai or the applicable Designated Distributor does not timely agree on all packaging and labeling used with Product (which must be compatible with Arena’s equipment) and deliver such necessary artwork. Arena shall have the right to subcontract the manufacture of all printed packaging materials, including labels, and Arena shall be responsible for all such subcontractors as provided in Section 2.4.